| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 2.935 | 10.332 | 22.391 | 27.305 |
| Total Income - EUR | 0 | 4 | 920 | 0 | 0 | 0 | 3.052 | 10.332 | 22.391 | 27.305 |
| Total Expenses - EUR | 685 | 81 | 37 | 36 | 35 | 630 | 3.269 | 3.365 | 15.775 | 19.505 |
| Gross Profit/Loss - EUR | -685 | -77 | 883 | -36 | -35 | -630 | -217 | 6.967 | 6.616 | 7.800 |
| Net Profit/Loss - EUR | -685 | -77 | 855 | -36 | -35 | -630 | -307 | 6.747 | 6.396 | 7.527 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Salva Research Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 1.578 | 0 | 545 | 272 | 0 |
| Current Assets | 5.231 | 5.101 | 5.388 | 5.253 | 5.116 | 2.812 | 3.987 | 6.790 | 8.053 | 10.802 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 173 | 179 | 87 | 92 | 97 | 100 | 277 | 2.974 | 75 | 4.964 |
| Cash | 5.058 | 4.923 | 5.302 | 5.161 | 5.019 | 2.711 | 3.710 | 3.816 | 7.978 | 5.838 |
| Shareholders Funds | 4.737 | 4.611 | 5.388 | 5.253 | 5.116 | 4.389 | 3.984 | 6.148 | 6.445 | 7.575 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 495 | 490 | 0 | 0 | 0 | 0 | 3 | 1.187 | 1.880 | 3.227 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7320 - 7320" | |||||||||
| CAEN Financial Year |
7320
|
|||||||||
Comments - Salva Research Srl